Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q3 FY2023-24 Earnings Call held on 24th January, 2024 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320240124150895.mp3
Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2023-24 Earnings Call held on 20th October, 2023 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320231020149273.mp3
Transcript of the Earnings Call held on Friday, July 21, 2023 for the first quarter ended June 30, 2023 is available on the Company''s website. The said transcript is also attached.
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, April 28, 2023 for the Fourth quarter and year ended March 31, 2023 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Earnings%20Call%20Transcript_28_April_2023.pdf The said transcript is also attached.
Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q4 FY2022-23 Earnings Call held on 28th April, 2023 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320230428146371.mp3
